We are a young, internationally connected research group. Our group consists of both wet lab biologists and bioinformaticians, and practically all of our projects combine these two worlds. We study how the transcriptional networks are rewired in cancer cells, and how this rewiring could be exploited as cancer therapy. The major disease model of interest is prostate cancer, and particularly the aggressive forms of this disease, which do not respond well to the existing therapies.